TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 1 | -2 | -8 | -5 | 1 | -28 | 42 | 0 |
| P | %wins | 0 | 0 | 0 | 100 | 0 | 100 | 33 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/3/08 20:51 | 10/2/08 | MITI | Micromet, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Berriman John E | 2M | D | P.d | 50 | 4.21 | 1 | 12 | New | 12 | D | 58 | 117 | 108 | 58 | -39 | -31 | -11 | 1 | -2 | -8 | -5 | 1 | -28 | 42 | |
6/1/04 18:58 | 5/27/04 | ALNY | Alnylam Pharmaceuticals Inc | Health | Drug | Pharmaceutical Preparations | Berriman John E | DT | P | 1,560 | 6.00 | 0 | 260 | 2 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |